Tarik Azzi

6PUBLICATIONS
50CO-AUTHORS
Haematological tumoursCellular immunologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Innate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 23, 2024
A metabolic dependency of EBV can be targeted to hinder B cell transformation.

Bojana Müller-Durovic, Jessica Jäger, Christine Engelmann

|Oct 20, 2021
CD4 + T cells are found within endemic Burkitt lymphoma and modulate Burkitt lymphoma precursor cell viability and expression of pathogenically relevant Epstein-Barr virus genes.

Semjon Sidorov, Lara Fux, Katja Steiner

|May 16, 2021
Reduced frequency of cytotoxic CD56dim CD16+ NK cells leads to impaired antibody-dependent degranulation in EBV-positive classical Hodgkin lymphoma.

Elena Pánisová, Anna Lünemann, Simone Bürgler

|Apr 07, 2020
Immunosuppressive FK506 treatment leads to more frequent EBV-associated lymphoproliferative disease in humanized mice.

Nicole Caduff, Donal McHugh, Anita Murer

|May 31, 2019
CD8+ T cells retain protective functions despite sustained inhibitory receptor expression during Epstein-Barr virus infection in vivo.

Bithi Chatterjee, Yun Deng, Angelika Holler

|May 05, 2017
Two alternate strategies for innate immunity to Epstein-Barr virus: One using NK cells and the other NK cells and γδ T cells.

Zakia Djaoud, Lisbeth A Guethlein, Amir Horowitz

Pageof 1

Frequent Collaborators

3 joint publications

Christian Münz

2 joint publications

David Nadal

2 joint publications

Christoph Berger

1 joint publications

Zakia Djaoud